Gregory Wilding, PhD (Series Introduction) Professor Department of Biostatistics School of Public Health and Health Professions Director, CTSI BERD Core Michael LaMonte, PhD, MPH (Clinical Trials ...

Medically reviewed by Kate Colby, MPH Key Takeaways In a double-blind trial, neither the patient nor the researcher knows who gets the treatment.A placebo-controlled trial uses a fake drug to test ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Memorial Sloan Kettering Cancer Center's mission is to end cancer. To get there, the famed organization must keep improving clinical care and research, including clinical trials. It has as many as ...

Researchers from the National Institutes of Health are using large language models to develop an artificial intelligence framework to streamline the clinical trial matching process and more quickly ...

Walgreens sees a long runway for its two-year-old clinical trials business as it doubles down on its core retail pharmacy operations. Ramita Tandon, chief clinical trials officer, shared insights ...

A study featuring investigators from the University at Buffalo Clinical and Translational Science Institute (CTSI), Roswell Park Comprehensive Cancer Center, and CTSA (Clinical and Translational ...

For roughly 80% of our lives, we’re 25 miles or less from home — at work, at the supermarket, at school pickup. But when you ask a patient to join a clinical trial, you’re usually asking them to go ...